Montelukast sodium is described chemically as [ R E )]-1-[[[1-[3-[2-(7-chloro-2 quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1
Drug class: Leukotriene
It has been determined that montelukast is highly metabolized and typically so by the cytochrome P450 3A4, 2C8, and 2C9 isoenzymes
2
Montelukast is a medication that prevents and treats the symptoms of asthma and allergies
Drug Images What is montelukast? Montelukast oral tablet is a generic prescription drug
Montelukast is a potent, specific antagonist of leukotriene receptors 10,11 that was recently approved in the United States and other countries for the treatment of chronic asthma
Last
For example, montelukast is a weak acid with a pKa of 5
Children younger than 15 years of age—Use and dose must be determined by your doctor
Package Size
column
It exhibits a pH-dependent solubility pattern of increasing solubility above its pKa; simultaneously, it is freely Montelukast oral tablets are used to treat or help prevent symptoms of chronic asthma in adults and adolescents ages 15 years and older
3,7 In a 12-week, placebo-controlled study, we evaluated El montelukast se usa para prevenir sibilancias, dificultad para respirar, opresión en el pecho y tos causada por asma en adultos y niños mayores de 12 años
Se debe recomendar a los pacientes que sigan tomando montelukast tanto mientras su asma está controlada como durante los periodos de empeoramiento del asma
How much and how often should you use this Montelukast sodium is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older
Montelukast también está
Montelukast may be used concomitantly with inhaled corticosteroids to control asthma and to reduce the dose of inhaled COMPOSICIÓN: Composición cualitativa y cuantitativa Cada TABLETA RECUBIERTA de 10 mg contiene: Montelukast sódico 10,4 mg equivalente a Montelukast base 10 mg Excipientes: Celulosa microcristalina (Avicel PH 102), povidona K30 (Kollidón K30), croscarmelosa sódica (Acdisol), estearato de magnesio, opadry II White 85G18490
7) , ,
istradefylline will increase the level or effect of montelukast by affecting hepatic/intestinal enzyme CYP3A4 metabolism
It is also approved to relieve seasonal and perennial allergic rhinitis symptoms
Stefano Fogli et al